Hunan Er-Kang Pharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Hunan Erkang Pharmaceutical Co., Ltd. was established in 2003 and is a high-tech listed enterprise (SZ.300267) with core advantages in the entire pharmaceutical manufacturing industry chain. It is an important promoter and setter of Chinese pharmaceutical excipient industry standards. The company takes "everything for the safety of drugs" as its mission, relying on two high standard national scientific research platforms, the "National Medical Auxiliary Materials Engineering Technology Research Center" and the "National Enterprise Technology Center", guided by technological innovation, and driven by the improvement of drug quality and safety and industry standards, has developed into a multinational enterprise group that integrates pharmaceutical intermediates, raw materials, pharmaceutical excipients, pharmaceutical preparations, traditional Chinese medicine, and the big health industry. The company has set up multiple drug production and research and development bases in countries and regions along the "the Belt and Road", and its products are distributed in more than 30 countries and regions. The company has won multiple honors such as "Key High tech Enterprise of the National Torch Plan", "China's Most Valuable Pharmaceutical Listed Company", "Top 100 of China's Pharmaceutical Industry", and "Xinhua News Agency Ethnic Brand Project". The company is an excellent enterprise in the pharmaceutical excipient industry in China, with 127 varieties of pharmaceutical excipients, 73 varieties of raw materials, and 282 approval numbers for finished drugs. Among them, starch plant capsules are core products with independent intellectual property rights, and their technology is internationally leading, which is a major breakthrough in the capsule industry. Starch capsule products have applied for 90 patents both domestically and internationally, and have won the first prize of the Hunan Provincial Science and Technology Progress Award. The tide is flat and the shore is wide, prompting people to enter, and the wind is blowing and setting sail at the right time. In the future, Erkang Pharmaceutical will adhere to the original aspiration of pharmaceutical professionals, focus on drug safety, actively build an integrated industrial ecosystem of "raw materials+preparations", promote the continuous improvement of enterprise value, and create a national pharmaceutical brand with international influence. |
| Headquarter | Changsha |
| Establish Date | 10/22/2003 |
| Listed Code | 300267.SZ |
| Listed Date | 9/27/2011 |
| Chairman | Shuai Fangwen. |
| CEO | Sun Qingrong. |
| Website | www.hnerkang.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
